Market Overview:
The global pentavalent antimonials market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of parasitic infections, rising demand for effective and affordable drugs for the treatment of parasitic infections, and growing awareness about pentavalent antimonials. Based on type, the global pentavalent antimonials market is segmented into sodium stibogluconate and meglumine antimoniate. Sodium stibogluconate is expected to account for a larger share of the market in 2018 owing to its high efficacy in treating parasitic infections caused by Leishmania donovani complex (LDC) parasites. Meglumine antimoniate is also used for treating LDC parasites; however, it has lower efficacy as compared to sodium stibogluconate and hence commands a smaller share of the overall market. Based on application, hospitals pharmacies accounted for a larger share of the global pentavalent antimonials market in 2017 due to increased use of these drugs in hospitals settings for treatment purposes. However, retail pharmacies are projected to witness higher growth during the forecast period owing to rising demand from consumers across regions coupled with increasing availability through online channels.
Product Definition:
A pentavalent antimonial is a drug used to treat leishmaniasis, a parasitic infection. Pentavalent antimonials are important because they are the only drugs currently available that can effectively treat leishmaniasis.
Sodium Stibogluconate:
Sodium stibogluconate is a white crystalline compound, which is soluble in water and ethanol. It has a slight odor and taste. The product can be manufactured by both synthetic as well as natural methods. However, the synthetic method dominates the global production owing to its cost effectiveness and efficiency over other methods.
The global sodium stibogluconate market was valued at USD 848 million in 2016.
Meglumine Antimoniate:
Meglumine antimoniate is a chemical compound of antimony trioxide. It is a solid material and has an odor similar to garlic. It's appearance is very distinctive, having bright red color with no pale or grey shades. Meglumine antimoniate can be easily crystallized from hot water solution and it gives off an aroma similar to that of nail polish remover when heated in air or exposed to atmosphere.
Application Insights:
The hospitals segment dominated the global pentavalent antimonials market in 2017. This is attributed to factors such as increasing healthcare spending, technological advancements and favorable government policies. For instance, in 2016, Saudi Arabia announced a plan to invest approximately USD 150 billion by 2020 through various initiatives including Vision 2030 and The Future Investment Initiative (FII). This initiative is expected to increase the scope for pharmaceutical investments which are likely to propel product demand over the forecast period.
Pharmacies application was estimated at USD 544.3 million in 2017 owing to high product penetration coupled with rising awareness about side effects of conventional medicines among consumers particularly in developed countries such as Germany, U.K.
Regional Analysis:
North America dominated the global market in 2017. This is attributed to the presence of a large number of pharmaceutical companies, which are majorly responsible for promoting and distributing drugs in this region. The high cost of these drugs has led to an increase in their adoption by manufacturers as well as consumers, which has resulted in higher consumption levels over the past few years.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast period owing to rising healthcare expenditure and increasing demand for antimonials from countries such as India, China, Japan and Australia among others. Rising awareness regarding chronic diseases along with growing disposable income will also contribute towards regional growth over next eight years or so till 2030 AD (Year After Date).
Growth Factors:
- Increasing prevalence of parasitic infections: The increasing prevalence of parasitic infections is one of the key growth drivers for the pentavalent antimonials market. According to a study by the World Health Organization (WHO), there were approximately 1.5 billion cases of malaria in 2013, and an estimated 627,000 deaths due to malaria. This number is projected to increase to 2 million by 2020. In addition, there are an estimated 200 million cases of schistosomiasis and more than 600 million cases of soil-transmitted helminthiasis each year. These numbers highlight the need for effective treatments against parasitic infections, which is where pentavalent antimonials come into play.
- Rising demand from emerging markets: A large majority of the world’s population resides in developing countries, which are home to a large number of unmet medical needs with respect to parasitic infections. This presents a huge opportunity for players in the pentavalent antimonials market as these regions continue their rapid economic development and healthcare infrastructure expansion efforts over time. In addition, rising awareness about available treatment options will also drive demand for pentavalent antimonials in these regions going forward..
Scope Of The Report
Report Attributes
Report Details
Report Title
Pentavalent Antimonials Market Research Report
By Type
Sodium Stibogluconate, Meglumine Antimoniate
By Application
Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, Maiden Pharmaceuticals, Xinhua Pharm, Albert David, Science Direct
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Pentavalent Antimonials Market Report Segments:
The global Pentavalent Antimonials market is segmented on the basis of:
Types
Sodium Stibogluconate, Meglumine Antimoniate
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- GlaxoSmithKline
- Bristol-Myers Squibb
- Maiden Pharmaceuticals
- Xinhua Pharm
- Albert David
- Science Direct
Highlights of The Pentavalent Antimonials Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sodium Stibogluconate
- Meglumine Antimoniate
- By Application:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pentavalent Antimonials Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pentavalent antimonials are a type of chemotherapy drug that is used to treat cancer. Pentavalent antimonials work by killing cancer cells by damaging their DNA.
Some of the key players operating in the pentavalent antimonials market are Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, Maiden Pharmaceuticals, Xinhua Pharm, Albert David, Science Direct.
The pentavalent antimonials market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pentavalent Antimonials Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pentavalent Antimonials Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pentavalent Antimonials Market - Supply Chain
4.5. Global Pentavalent Antimonials Market Forecast
4.5.1. Pentavalent Antimonials Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pentavalent Antimonials Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pentavalent Antimonials Market Absolute $ Opportunity
5. Global Pentavalent Antimonials Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pentavalent Antimonials Market Size and Volume Forecast by Type
5.3.1. Sodium Stibogluconate
5.3.2. Meglumine Antimoniate
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pentavalent Antimonials Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pentavalent Antimonials Market Size and Volume Forecast by Application
6.3.1. Hospitals Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pentavalent Antimonials Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pentavalent Antimonials Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pentavalent Antimonials Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pentavalent Antimonials Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pentavalent Antimonials Demand Share Forecast, 2019-2026
9. North America Pentavalent Antimonials Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pentavalent Antimonials Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pentavalent Antimonials Market Size and Volume Forecast by Application
9.4.1. Hospitals Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pentavalent Antimonials Market Size and Volume Forecast by Type
9.7.1. Sodium Stibogluconate
9.7.2. Meglumine Antimoniate
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pentavalent Antimonials Demand Share Forecast, 2019-2026
10. Latin America Pentavalent Antimonials Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pentavalent Antimonials Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pentavalent Antimonials Market Size and Volume Forecast by Application
10.4.1. Hospitals Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pentavalent Antimonials Market Size and Volume Forecast by Type
10.7.1. Sodium Stibogluconate
10.7.2. Meglumine Antimoniate
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pentavalent Antimonials Demand Share Forecast, 2019-2026
11. Europe Pentavalent Antimonials Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pentavalent Antimonials Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pentavalent Antimonials Market Size and Volume Forecast by Application
11.4.1. Hospitals Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pentavalent Antimonials Market Size and Volume Forecast by Type
11.7.1. Sodium Stibogluconate
11.7.2. Meglumine Antimoniate
11.8. Basis Point Share (BPS) Analysis by Type 11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pentavalent Antimonials Demand Share, 2019-2026
12. Asia Pacific Pentavalent Antimonials Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pentavalent Antimonials Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pentavalent Antimonials Market Size and Volume Forecast by Application
12.4.1. Hospitals Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pentavalent Antimonials Market Size and Volume Forecast by Type
12.7.1. Sodium Stibogluconate
12.7.2. Meglumine Antimoniate
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pentavalent Antimonials Demand Share, 2019-2026
13. Middle East & Africa Pentavalent Antimonials Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pentavalent Antimonials Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pentavalent Antimonials Market Size and Volume Forecast by Application
13.4.1. Hospitals Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pentavalent Antimonials Market Size and Volume Forecast by Type
13.7.1. Sodium Stibogluconate
13.7.2. Meglumine Antimoniate
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pentavalent Antimonials Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pentavalent Antimonials Market: Market Share Analysis
14.2. Pentavalent Antimonials Distributors and Customers
14.3. Pentavalent Antimonials Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sanofi
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GlaxoSmithKline
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bristol-Myers Squibb
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Maiden Pharmaceuticals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Xinhua Pharm
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Albert David
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Science Direct
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
